Professor Syed Haq is a Professor of Medicine - specialises in treating the ageing skin and immune system. He performs cosmetic procedures such as botulinum toxin, dermal fillers and PDO/PCL threads.

Prof. Haq has studied at Guy’s Hospital, Imperial College University, Harvard Medical School and Massachusetts General Hospital, and Tufts New England Medical Center, USA.

He has overseen several MHRA-registered phase IIa/b clinical trials in the UK and has been awarded 2 x US FDA Orphan Drug Designations IND.
Co-PI for the latest phase IV clinical trial using Alluzience

KOL and Consultant for Croma, Hugel, Allergan Aesthetics and Galderma

He is a multi-award-winning clinician/scientist - AstraZeneca, American Heart Association, Medical Research Council and Wellcome Trust.

Prof. Haq is the CMO and Founder of BioImmunitas Ltd which is focused on developing therapeutics for targeting systemic inflammatory disorders by recalibration of the innate immune system.

Prof. Haq runs his facial aesthetics clinic in London, Belfast and Dublin, treating 1000s patients per year

Featured in the Times, Hello Magazine, Daily Mail, Tatler and TV - KAS2 etc